Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 62

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain

Viedma, Esther, Juan, Carlos, Villa, Jennifer, Barrado, Laura, Orellana, M. Ángeles, Sanz, Francisca, Otero, Joaquín R., Oliver, Antonio, Chaves, Fernando·2012·Emerging Infectious Diseases

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1808.111234

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 35

  1. Aloush, 2006, Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact., Antimicrob Agents Chemother, 50, 43, 10.1128/AAC.50.1.43-48.2006 · DOI · Paper page
  2. Livermore, 2002, Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?, Clin Infect Dis, 34, 634, 10.1086/338782 · DOI · Paper page
  3. Queenan, 2007, Carbapenemases: the versatile β-lactamases., Clin Microbiol Rev, 20, 440, 10.1128/CMR.00001-07 · DOI · Paper page
  4. Cornaglia, 2011, Metallo-β-lactamases: a last frontier for β-lactams?, Lancet Infect Dis, 11, 381, 10.1016/S1473-3099(11)70056-1 · DOI · Paper page
  5. Walsh, 2005, Metallo-beta-lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005 · DOI · Paper page
  6. Poirel, 2000, Characterization of VIM-2, a carbapenem-hydrolyzing metallo β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France., Antimicrob Agents Chemother, 44, 891, 10.1128/AAC.44.4.891-897.2000 · DOI · Paper page
  7. Riccio, 2001, In70 of plasmid pAX22, a blaVIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette., Antimicrob Agents Chemother, 45, 1249, 10.1128/AAC.45.4.1249-1253.2001 · doi:10.1128/aac.45.4.1249-1253.2001
  8. Obritsch, 2004, National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002., Antimicrob Agents Chemother, 48, 4606, 10.1128/AAC.48.12.4606-4610.2004 · DOI · Paper page
  9. Leibovici, 1998, The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection., J Intern Med, 244, 379, 10.1046/j.1365-2796.1998.00379.x · DOI · Paper page
  10. Gutiérrez, 2007, Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals., Antimicrob Agents Chemother, 51, 4329, 10.1128/AAC.00810-07 · doi:10.1128/aac.00810-07
  11. Rossolini, 2008, First countrywide survey of acquired metallo-β-lactamase in gram-negative pathogens in Italy., Antimicrob Agents Chemother, 52, 4023, 10.1128/AAC.00707-08 · doi:10.1128/aac.00707-08
  12. Juan, 2008, Characterization of the new metallo-β-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain., Antimicrob Agents Chemother, 52, 3589, 10.1128/AAC.00465-08 · DOI
  13. Peña, 2007, Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications., Clin Microbiol Infect, 13, 1026, 10.1111/j.1469-0691.2007.01784.x · doi:10.1111/j.1469-0691.2007.01784.x
  14. Riera, 2011, Pseudomonas aeruginosa carbapenem resistance mechanism in Spain: impact on the activity of imipenem, meropenem and doripenem., J Antimicrob Chemother, 66, 2022, 10.1093/jac/dkr232 · DOI · Paper page
  15. Viedma, 2009, Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum b-lactamases GES-1 and GES-5 in Spain., Antimicrob Agents Chemother, 53, 4930, 10.1128/AAC.00900-09 · DOI
  16. Cantón, 2000, Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing., J Clin Microbiol, 38, 1339, 10.1128/JCM.38.4.1339-1346.2000 · doi:10.1128/jcm.38.4.1339-1346.2000
  17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, vol. 26, no. 3. 16th informational supplement. M100–S16. Wayne (PA): The Institute; 2006.
  18. Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing., J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995 · DOI · Paper page
  19. Curran, 2004, Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa., J Clin Microbiol, 42, 5644, 10.1128/JCM.42.12.5644-5649.2004 · DOI · Paper page
  20. Pournaras, 2003, Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4., J Antimicrob Chemother, 51, 1409, 10.1093/jac/dkg239 · doi:10.1093/jac/dkg239
  21. Gibb, 2002, Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7)., Antimicrob Agents Chemother, 46, 255, 10.1128/AAC.46.1.255-258.2002 · DOI · Paper page
  22. Crespo, 2004, Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia., J Clin Microbiol, 42, 5094, 10.1128/JCM.42.11.5094-5101.2004 · DOI
  23. Ryoo, 2009, Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital., Diagn Microbiol Infect Dis, 63, 115, 10.1016/j.diagmicrobio.2008.08.019 · DOI
  24. Deplano, 2007, Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in Belgium., Euro Surveill, 12
  25. Lolans, 2005, First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States., Antimicrob Agents Chemother, 49, 3538, 10.1128/AAC.49.8.3538-3540.2005 · DOI
  26. Castanheira, 2009, Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, −5, −6, and −11 and the newly characterized VIM-18)., Antimicrob Agents Chemother, 53, 1225, 10.1128/AAC.01011-08 · DOI
  27. García-Castillo, 2011, Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals., J Clin Microbiol, 49, 2905, 10.1128/JCM.00753-11 · DOI
  28. Cholley, 2011, Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types., J Clin Microbiol, 49, 2578, 10.1128/JCM.00102-11 · DOI
  29. Nemec, 2010, Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic., Res Microbiol, 161, 234, 10.1016/j.resmic.2010.02.002 · doi:10.1016/j.resmic.2010.02.002
  30. Libisch, 2009, Identification of two multidrug-resistant Pseudomonas aeruginosa clonal lineages with a countrywide distribution in Hungary., Curr Microbiol, 58, 111, 10.1007/s00284-008-9285-7 · DOI
  31. Elias, 2010, Nosocomial outbreak of VIM-2 metallo-β-lactamase producing Pseudomonas aeruginosa associated with retrograde urography., Clin Microbiol Infect, 16, 1494, 10.1111/j.1469-0691.2010.03146.x · DOI
  32. Pagani, 2005, Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase., J Clin Microbiol, 43, 3824, 10.1128/JCM.43.8.3824-3828.2005 · DOI
  33. Duljasz, 2009, First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria., Antimicrob Agents Chemother, 53, 2221, 10.1128/AAC.01573-08 · doi:10.1128/aac.01573-08
  34. Acosta, 2011, Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain., Emerg Infect Dis, 17, 1064, 10.3201/eid1706.091866 · doi:10.3201/eid1706.091866
  35. Tam, 2008, Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint., Clin Infect Dis, 46, 862, 10.1086/528712 · DOI

Cited by

See all 62

Metadata

Authors
Viedma, E., Juan, C., Villa, J., Barrado, L., Orellana, M. Á., Sanz, F., Otero, J. R., Oliver, A., & Chaves, F.
Venue
Emerging Infectious Diseases
Published
2012-08
Volume
18
Issue
8
ISSN
  • 1080-6040
  • 1080-6059
Cited by
62
References
1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain. https://app.cochat.ai/papers/10.3201/eid1808.111234
The paper
Viedma, E., Juan, C., Villa, J., Barrado, L., Orellana, M. Á., Sanz, F., Otero, J. R., Oliver, A., & Chaves, F. (2012). VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain. Emerging Infectious Diseases. https://doi.org/10.3201/eid1808.111234

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.